Dexcom Inc. Stock
Price
Target price
€61.40
€61.40
-0.970%
-0.6
-0.970%
€73.56
22:25 / Tradegate
WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dexcom Inc. Stock
Dexcom Inc. shows a slight decrease today, losing -€0.600 (-0.970%) compared to yesterday.
The stock is one of the favorites of our community with 50 Buy predictions and 2 Sell predictions.
With a target price of 73 € there is a slightly positive potential of 18.89% for Dexcom Inc. compared to the current price of 61.4 €.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | -0.970% | -2.532% | 1.987% | -16.475% | 7.467% | -45.322% | -31.650% |
| Baxter International | -1.160% | 11.367% | 16.356% | -25.477% | 18.770% | -53.261% | -71.900% |
| Teleflex Inc. | 0.260% | 3.373% | 1.704% | 13.400% | 11.176% | -47.500% | -66.450% |
| Idexx Laboratories Inc. | -2.640% | -0.961% | 2.152% | 6.675% | -17.174% | 9.647% | -6.885% |
Comments
DexCom (DXCM) had its "buy" rating reaffirmed by Benchmark Co..
Show more
Ratings data for DXCM provided by MarketBeat
DexCom (DXCM) is now covered by Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $86.00 price target on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom (DXCM) had its "overweight" rating reaffirmed by Piper Sandler.
Show more
Ratings data for DXCM provided by MarketBeat
News
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Key Points
- Interested in Teladoc Health, Inc.? Here are five stocks we like better.
- With the GLP-1 agonist market still growing at a rapid pace, companies outside of the pharma industry are
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?
Diabetes management is evolving rapidly as the industry innovates to treat the more than 40 million Americans with type 1 or type 2 diabetes. Deciding between two leaders in monitoring and
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day
DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for